MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
0.524
+0.024 (4.76%)
Dec 20, 2024, 4:00 PM EST - Market closed
MiNK Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
31
Market Cap
20.72M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | 689.63K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Concord Medical Services Holdings | 64.91M |
Bionano Genomics | 33.33M |
American Shared Hospital Services | 24.97M |
BioLineRx | 21.99M |
Bolt Biotherapeutics | 9.78M |
Affimed | 6.29M |
INKT News
- 3 days ago - MiNK Therapeutics to Present iNKT Cell Therapy in Gastric Cancer at ASCO GI Annual Meeting - GlobeNewsWire
- 5 weeks ago - MiNK Therapeutics, Inc. (INKT) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 5 weeks ago - MiNK Therapeutics to Provide Corporate Update and Third Quarter 2024 Financial Report - GlobeNewsWire
- 6 weeks ago - MiNK's iNKT Cell Therapy Shows Potential for Optimal Multi-Combination for Resistant Solid Cancers at SITC 2024 - GlobeNewsWire
- 7 weeks ago - MiNK Therapeutics Announces Appointment of Dr. Robert Kadlec to Board of Directors - GlobeNewsWire
- 2 months ago - MiNK Therapeutics and Autonomous Therapeutics Announce Collaboration to Develop Novel Therapies Targeting Metastatic Tumors - GlobeNewsWire
- 2 months ago - MiNK Therapeutics to Present Data From iNKT Cell Programs at SITC 2024 - GlobeNewsWire
- 3 months ago - MiNK Therapeutics to Participate in H.C. Wainwright Global Investment Conference - GlobeNewsWire